Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

Benzer Materyaller

• Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
  Yazar:: Christopher Aled Chamberlain, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-03-01)
• Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
  Yazar:: Marco Donia, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-07-01)
• Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
  Yazar:: Marco Donia, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-10-01)
• Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial
  Yazar:: Cathrine Lund Lorentzen, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-10-01)
• Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab
  Yazar:: Mads Hald Andersen, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-05-01)